Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

NCT06599775 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Resectable Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Adebrelimab injection
DRUG: Albumin-Bound Paclitaxel
DRUG: Carboplatin injection

Sponsor

Shanghai Zhongshan Hospital